ProSTAR Team

Our current ProSTAR/PSTP community hosts a vibrant mix of trainees at all levels, and a continuum of graduates who are currently STAR fellows. Our graduates continue subspecialty training in all medicine subspecialties, and continue in a successful and validated pipeline known to produce successful physician investigators in the areas of basic, translational, and clinical/health services research.

Resident Profiles

Sriram Anbil, MD

Sriram Anbil, MD

Dr. Anbil completed his MD at The University of Texas School of Medicine in San Antonio, and spent four years in the laboratory of Dr. Tayyaba Hasan and Massachusetts General Hospital, two as a research associate prior to medical school, and two as an HHMI Medical Research Fellow between his MS2 and MS3 years.

Kathleen Fenerty, MD

Kathleen Fenerty, MD

Dr. Kathleen Fenerty is an aspiring academic oncologist. She began her research career at the National Institutes of Health, where she was part of the Medical Research Scholars Program. There she had the opportunity to spend a year studying multimodal immunotherapies for prostate cancer.

Rui Li

Rui Li, MD, PhD

Dr. Li graduated from Zhejiang University School of Medicine and came to UCLA for his PhD study in Molecular and Medical Pharmacology. His research focused on the interactions between tumor microenvironment and progression. He developed a new combination therapywhich can effectively stimulate anti-tumor T cell responses in otherwise immunoresistant non-small cell lung cancer.

Rui Li, MD, PhD

Giuliana Repetti, MD

Dr. Giuliana Repetti began her research career in the lab of Dr. Lee Rubin at Harvard University studying the molecular and cellular basis of neurodegenerative diseases. As a University of Arizona medical student, she worked with Dr. Steven Goldman exploring the mechanisms behind a cardiac patch to treat heart failure.

Sohn Kim, MD, PhD

Sohn Kim, MD, PhD

Dr. Sohn Kim received his MD and PhD from the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program. His thesis work identified a mechanism of colonization resistance exerted by the intestinal microbiota against a common nosocomial pathogen, vancomycin-resistant Enterococcus, mediated by the narrow spectrum of activity of a novel microbiota-derived lantibiotic peptide.

Eileen Shiuan, MD, PhD

Eileen Shiuan, MD, PhD

Dr. Shiuan grew up in the Bay Area and went to undergrad at the University of Chicago, where she discovered her passion for oncology and cancer research and what real winters feel like. She subsequently fled south to Nashville, where she completed her MD and PhD in Cancer Biology at Vanderbilt University. 

Michael Raddatz

Michael Raddatz, MD, PhD

Dr. Raddatz completed his MD and PhD at Vanderbilt University where he studied inflammatory mechanisms of calcific aortic valve disease under the mentorship of Dr. David Merryman. His recent work with Dr. Alexander Bick leverages computational genomics to understand the pathophysiology of cardiovascular disease in patients with clonal hematopoiesis of indeterminate potential (CHIP).